baber/WOPTO huggingface dataset:
Patent FI-932066-A0 (FI)
Inventor: KOIVISTO SEPPO
IPC: E01B29/02
Filed: 1993-05-07
Abstract: PCT No. PCT/FI94/00175 Sec. 371 Date Nov. 7, 1995 Sec. 102(e) Date Nov. 7, 1995 PCT Filed May 6, 1994 PCT Pub. No. WO94/26978 PCT Pub. Date Nov. 24, 1994A lifting device for manipulating a track element at a manipulating location at least partially above a track transported to a manipulating location on a transport platform of a transport vehicle and includes a lifting device frame provided with power and drive system. Lifting elements are supported by the lifting device frame, for lifting the track element and transfer elements for moving the lifting device frame. At least one pair of support members supports and manipulates the transfer elements. The support members are mounted on a common subframe and at least one brace element is provided for movably mounting the common subframe to the lifting device frame, to allow the subframe to tilt and rotate with respect to the lifting device frame. Each of the support members has telescopic arms, movable between a retracted position in which the transfer elements are retractable upon the transport platform and an extended position in which the transfer elements are extended beyond the transport platform. Each of the support members has elevating members operating in a vertical direction, for moving the transfer elements in a vertical direction to change at least ground clearance of the transfer elements; and directional elements for rotating the transfer elements in a substantially horizontal plane for changing the traveling direction of the lifting device.
Patent FI-933474-A0 (FI)
Inventor: BIANCHI MARCO
IPC: C23C22/34
Filed: 1993-08-05
Abstract: Process for stainless steel pickling consisting in placing the material to be treated in a bath kept at a temperature ranging from 30 DEG C to 70 DEG C having the following initial composition:     a) H2SO4 150 g/l at least   b) Fe<3><+> 15 g/l at least   c) HF 40 g/l at least   d) H2O2 (added with known stabilizers) 1-20 g/l e) emulsifiers, wetting agents, polishing agents, acid attack inhibitors;  in the bath being fed continuously:   an air flow equal at least to 3 m<3>/h per m<3> bath min. and a stabilized H2O2 quantity adjusted to the bath redox potential to be kept at >/=250 mV. l
Patent FI-935356-A0 (FI)
Inventor: ZIMMER GERHARD
IPC: C01B15/013
Filed: 1993-11-30
Abstract: Aqueous hydrogen peroxide solutions contain variable amounts of carbon compounds following their production by the so-called anthraquinone process. Various methods are known for separating out carbon compounds, including those using organic ion exchangers or macro-porous organic adsorber resins. Described is a process using a solid adsorption agent, which can be regenerated without causing any problems, whereby the carbon content is reduced. The solid adsorption agent is a zeolite from the set of dealuminised H-Y-zeolites with a (SiO2/Al2O3) ratio equal to or greater than 20 or H-mordenites with a (SiO2/A12O3) ratio of at least 20.
Patent FI-955134-A0 (FI)
Inventor: PATT TOM E
IPC: C02F3/34
Filed: 1995-10-27
Abstract: Disclosed is a biologically pure culture of Aureobasidium pullmans deposited as NRRL 21064. Further disclosed are processes for decreasing the concentration of a type A/B chemical pollutants in an aqueous mixture containing the type A/B chemical pollutant which comprises adding sufficient amount of a fungal cyclic ether degrading microorganism to the aqueous mixture containing the chemical pollutant in the presence of a sufficient amount of cometabolite (type A chemical pollutant; not needed with type B) and a sufficient amount of oxygen.
Patent FI-961438-A0 (FI)
Inventor: CORDELL BARBARA LOUISE
IPC: A61K38/00
Filed: 1996-03-29
Abstract: This invention relates to compounds and pharmaceutical compositions, and methods for inhibiting or preventing the amyloid protein deposits in the brain which are associated with Alzheimer's disease and aged Down's syndrome patients. More particularly, it relates to the treatment of Alzheimer's disease.
Patent IL-80674-A0 (IL)
Title: Method and device for the stabilization of high-dynamics devices on a low-dynamics support
IPC: F41G5/24
Filed: 1986-11-17
Abstract: 1. Device for the stabilization of a device (4, 5, 6) which is mounted on a support (2) and which is movable relative to the latter, having, in comparsion with the support, a high speed of response to deviations from a rest position, having - a control loop (10), which is associated with the device and which includes a control device (15), for the control of deviations of the device from the rest position, which control loop exhibits a bandwidth matched to the speed of response of the device, - a sensor unit (3) for the detection of changes of position of the support in an inertial system with respect to at least three measurement axes, characterized in that - the sonsor unit is mounted as a central sensor block (3) on the support (2) and is equipped with sensors, the bandwidth of which is matched to the relatively slow speed of response of the support, - the device (4, 5, 6) is provided with angle pickups (14), which detect the position of the device relative to the support with respect to at least two axes and the output signals of which are fed to the control device (15) as the regulating quantity, and - devices (13) for the infraposition of the control loop by means of the signals which are delivered by the sensor block and which represent the position of the support in the inertial system as guide quantity, are provided in the control loop (10).
Patent IL-95059-A0 (IL)
Title: Composition for administration of nitrofurantoin
IPC: A61K9/00
Filed: 1990-07-12
Abstract: Compositions, for the administration of nitrofurantoin to a human or other animal, comprising: (a) a safe and effective amount of nitrofurantoin particulates having a surface consisting of nitrofurantoin monohydrate, wherein said particulates have a mean particle size greater than about 200 mesh size;  (b) nitrofurantoin monohydrate;  (c) an effective amount of suspending agent; and  (d) water; wherein the pH of said composition is from about 1 to about 6; and said nitrofurantoin monohydrate is dissolved in said water at saturation level. The nitrofurantoin of this invention are highly efficacious for the oral delivery of nitrofurantoin.
Patent IL-96474-A0 (IL)
Title: Method and apparatus for propelling and retarding off-road haulers
IPC: B60L7/10
Filed: 1990-11-26
Abstract: An improved method and apparatus for powering and controlling the operation of large diesel-electric off-road haulers of the type in which hauler drive wheels are propelled and retarded by DC electric wheel motors powered from on-board generators, optionally supplemented by DC power, from external trolley lines. In the disclosed system, thyristor-type converters connected into the system AC power grid are used to receive supplemental external power from DC trolley lines and supply it into the AC power distribution grid in the propel mode. The use of such thyristor-type converters makes possible the use of supplemental trolley line power without provision of separate switching or control gear to operate the DC wheel motors when trolley line power is received. Thyristor-type converters also may be used to supply current generated by wheel motors in the retarding mode to retarding resistors, making possible the use of the initial electrical power generated by the wheel motors to replace load requirements of the diesel engine, resulting in substantial fuel savings.
Patent IL-97701-A0 (IL)
Title: Device for generating hand function
IPC: A61F2/58
Filed: 1991-03-28
Abstract: A device for generating hand function, having an S-type splint (2) consisting of a forearm portion (4) extending along the palmar side of the forearm, a palmo-dorsal transition portion (6) leading to a dorsal portion (8) extending across the dorsal side of the carpal bones of the hand, and a palmar portion (10), at least the end of which touches the palm of the hand of the wearer of the device at least indirectly, and a plurality of electrodes (I to V), at least indirectly mounted on the splint (2) in positions in which they can make contact with skin portions directly overlying muscles to be stimulated. The electrodes (I to V) are connectable to an electronic circuit (47) adapted to produce, upon activation, stimulation currents delivered via combinations of the electrodes in predetermined, timed sequences to preselected groups of muscles. At least one switch (16,18) is actuatable by the wearer of the device, by which switch the predetermined, timed sequences can be initiated. <IMAGE>
Patent SE-9202986-A0 (SE)
Title: Tungkontrollerat styrsystem
Inventor: ANDRÉ ALM
IPC: G05G1/52
Filed: 1992-10-12
Abstract: Sammandrag. Uppfinningen avser ett tungkontrollerat styrsystem. Anliggningstrycket hos den manskliga tungan mot avkanningsytor (8, 9, 10, 11) i en gjutplatta (6) placerad mot gommen eller overkakens tandrad ger upphov till kapacitans-, induktans- eller resistansandringar hos MO hiirande sensorer (1,2, 3,4, 19). Dessa andringar overfors tradlost i ett elektromagnetiskt fait eller vagrorelse till en avlasningsenhet (7) placerad pa eller i anslutning till huvudet hos Waren. Fran avlasningsenheten (7) sker tiliforsel av energisensorema (1, 2, 3, 4, 19) samt till densamma direkt eller indirekt overforing av det mot anliggningstrycket svarande matvardet, t ex genom antennspolar (17, 18). Avkanningsytoma (8, 9, 10, 11) har karakteristisk formoch topografiskt ytmOnster. Sensorernas (1, 2, 3, 4, 19) overforingsfunktion har i vissa fall kontinuerlig, i vissa fall diskontinuerlig, karakteristik.
Patent FI-20085430-A0 (FI)
Inventor: SVAHNSTROEM NICLAS
IPC: H04L/
Filed: 2008-05-09
Abstract: Amethod is provided where a first policy control decision is generated (3-61) in a visited network (PCRF1), and a second policy control decision is generated (3-62) in a home network (PCRF2). The visited network (PCRF1) receives the second policy control decision and compares (3-7b) the first policy control decision and the second policy control decision. If they are not in line with each other, the visited network (PCRF1) indicates (3-7c) to the home network (PCRF2) that the first policy control decision and the second policy control decision are not in line with each other. In response to that, information on a policy requirement of the home network (PCRF2) is provided (3-7d) to the visited network (PCRF1). On the basis of the first policy control decision and the policy requirement, the visited network (PCRF1) generates (3-7e) a negotiated policy control decision to be used for a user terminal.
Patent IL-104004-A0 (IL)
Title: Pressureless sintering of whisker reinforced alumina composites
IPC: C04B35/111
Filed: 1992-12-04
Abstract: PCT No. PCT/US92/11379 Sec. 371 Date Nov. 24, 1993 Sec. 102(e) Date Nov. 24, 1993 PCT Filed Dec. 3, 1992 PCT Pub. No. WO93/11086 PCT Pub. Date Jun. 10, 1993A composite and pressureless sintering process for making whisker-reinforced alumina composites using about 1 to about 7.5 wt. % of a nitride modifier consisting essentially of silicon nitride, aluminum nitride, or mixtures thereof that produces a sintered body having a density of greater than 95% theoretical.
Patent IL-105372-A0 (IL)
Title: 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and pharmaceutical compositions containing them
IPC: A61K31/42
Filed: 1993-04-14
Abstract: Compounds of the formula <CHEM>  wherein: R1 is alkyl, alkoxy, hydroxy, cycloalkyl, hydroxyalkyl, alkoxyalkyl or hydroxyalkoxy;     Y is alkylene of 3 to 9 carbon atoms, R2 and R3 independently are hydrogen, alkyl, alkoxy, halo, trifluoromethyl or nitro; R4 is alkoxy, hydroxy, halomethyl, dihalomethyl, trihalomethyl, cycloalkyl, alkoxycarbonyl, hydroxyalkyl, alkoxyalkyl, alkanecarbonyloxyalkyl, cyano, 2,2,2-trifluoroethyl, (4-methylphenyl)sulfonyloxymethyl, N=Q or CON=Q, where N=Q is amino, alkylamino or dialkylamino; or pharmaceutically acceptable acid-addition salts thereof are useful as antiviral agents. Preferred compounds are those wherein Y is alkylene of 3 to 5 carbon atoms and especially when R2 and R3 are in the 2- and 6- positions of the phenyl ring.
Patent IL-116166-A0 (IL)
Title: Process for the preparation of 5-amino-2 4 6-triiodoisophthalic acid dichloride
IPC: C07C229/62
Filed: 1995-11-28
Abstract: PCT No. PCT/EP95/04635 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Nov. 24, 1995 PCT Pub. No. WO96/16927 PCT Pub. Date Jun. 6, 1996A process for the preparation of 5-amino-2,4,6-triiodoisophthalic acid dichloride by chlorinating 5-amino-2,4,6-triiodoisophthalic acid with thionyl chloride in the presence of a suitable solvent and of a tertiary amine salt or quaternary ammonium salt in a molar ratio from 1;1 to 1;2 with respect to 5-amino-2,4,6-triiodoisophathalic acid is described. 5-amino-2,4,6-triiodoisophthalic acid dichloride is an intermediate useful for the preparation of iodinated contrast agents.
Patent IL-119971-A0 (IL)
Title: Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
IPC: C07C69/34
Filed: 1997-01-07
Abstract: The present invention relates to a novel class of compounds for treating hyperlipidemia, obesity and impaired glucose tolerance/noninsulin dependent diabetes mellitus without adversely affecting energy metabolism, and pharmaceutical compositions comprising the aforementioned compounds for the treatment of obesity, hyperlipidemia and maturity-onset diabetes.
Patent IL-122894-A0 (IL)
Title: Fungicidal mixtures
IPC: A01N47/34
Filed: 1996-07-03
Abstract: PCT No. PCT/US96/11346 Sec. 371 Date Jan. 9, 1997 Sec. 102(e) Date Jan. 9, 1997 PCT Filed Jul. 3, 1996 PCT Pub. No. WO97/02745 PCT Pub. Date Jan. 30, 1997Advantageous combinations of an oxazolidinone and cymoxanil (or their agriculturally suitable salts) and their use to control fungus disease in plants are disclosed, the oxazolidinone having the formula
Patent IL-142923-A0 (IL)
Title: Process for applying discrete web portions to a receiving web
IPC: A61F13/15
Filed: 1999-11-17
Abstract: The invention provides a process comprising the steps of:   feeding a web into a web transfer apparatus 1 at a first speed (V1);     cutting a web portion 101 off the web 100; and accelerating the web portion 101 to the speed (V2)of a receiving web 200, separating the web portion 101 into at least a first web portion 102 and a second web portion 103 by means of at least a second cut; moving the web portions 102, 103 relative to each other so that they are spaced apart; and applying each of the spaced apart web portions 102, 103 to the receiving web 200.   <IMAGE>
Patent IL-148095-A0 (IL)
Title: Method and apparatus for multiple access over a communication channel
IPC: H04B1/707
Filed: 2000-08-14
Abstract: This invention is a multiple access communication technique by which a multitude of transmitters communicate with receivers using direct sequence spread spectrum signaling. The direct sequence codes are reused by a large number of simultaneous transmitters, so the system is named Code Reuse Multiple Access ("CRMA"). This reuse method requires only a small number of codes relative to the number of simultaneous transmitters, and can use as few as one code for all the users. The direct sequence codes are not required to have special properties such as maximal length. The lengths of the spreading codes employed are not necessarily related to the bit or symbol interval. CRMA can be implemented on a Paired Carrier Multiple Access ("PCMA") system with or without a novel receiver structure which is also described.
Patent IL-152308-A0 (IL)
Title: Method for generating intra-particle morphological concentration/density maps and histograms of a chemically pure particulate substance
IPC: G01N15/14
Filed: 2001-04-19
Abstract: An method for generating intra-particle morphological concentration/density maps and histograms of a chemically pure particulate substance. Spectral imaging, in general, and focus-fusion multi-layer spectral imaging, in particular, combined with pattern recognition classification analysis are performed on individual particles for forming sets of single-particle spectral fingerprint data, characterized by single-particle spectral fingerprint spectra. Spectral shifts are identified in the single-particle spectral fingerprint data, for forming intra-particle region groups featuring sub-sets of intra-particle spectral fingerprint pattern data, each characterized by an intra-particle spectral fingerprint pattern spectrum. Each intra-particle region group is associated with different types of intra-particle morphological regions, where each region type is associated with a surface concentration value and a density value of the chemically pure substance in that imaged particle, for forming intra-particle morphological concentration/density data, which is used for generating an intra-particle morphological concentration/density map. A morphological concentration/density histogram, or frequency distribution, is generated from the intra-particle morphological concentration/density data, for illustrating global morphological distribution of concentration, and density of the chemically pure substance throughout the entire multi-particle substance.
Patent IL-156261-A0 (IL)
Title: Pyrroloquinoline and pyridoquinoline derivatives and pharmaceutical compositions containing the same
IPC: A61K31/4745
Filed: 2001-12-19
Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I)or pharmaceutically acceptable salt forms thereof, wherein is R<1>, R<6a>, R<6b>, R<7>, R<8>, R<9>, X, b, m, and n are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.
Patent IL-161468-A0 (IL)
Title: Method of producing human beta cell lines
IPC: C12N5/10
Filed: 2002-10-18
Abstract: The invention provides a method of regenerating pancreas function in an individual by transplantation of an effective amount of functional pancreatic cells derived from embryonic pancreatic cells not older than 10 weeks of development. Also provided is the method of producing functional animal pancreatic cell, more precisely an immortalized human beta cell line. The invention also provides a method of treatment of diabetics. Also are provided pancreatic beta cells as a medicament to treat diabetics.
Patent IL-164162-A0 (IL)
Title: 5Ht2c receptor modulators
IPC: A61P13/02
Filed: 2003-04-11
Abstract: The present relation relates to 8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine   
or a pharmaceutically acceptable salt, solvate, or hydrate thereof for the treatment of a disorder of the central nervous system selected from: depression, atypical depression, a bipolar disorder, an anxiety disorder, an obsessive-compulsive disorder, a social phobia, a panic state, a sleep disorder, sexual dysfunction, psychosis, schizophrenia, migrane or other condition associated with cephalic pain or other pain, raised intracranial pressure, epilepsy, a personality disorder, an age-related behavioral disorder, a behavioral disorder associated with dementia, an organic mental disorder, a mental disorder in childhood, aggressivity, an age-related mental disorder, chronic fatigue syndrome, drug addiction, alcohol addiction, bulimia, anorexia nervosa, or premenstrual tension.
Patent IL-184160-A0 (IL)
Title: A base for fitting infants seats to motorcars
Filed: 2007-06-24
Abstract: This base comprises anchoring means (9 and 10) being operable to engage a receiving element being provided in the motorcar, said base being characterized in that the anchoring means (9 and 10) are to be actuated by means of a pneumatic device (4) being in its turn actuated by means of a control (13) being provided at said base (1), said pneumatic device and control, this latter being made up by an articulated lever (14), being fitted to a framework (2). The piston (5) of the pneumatic device (4) is fitted to the transversal carrier (8) of the anchoring means (9 and 10) by means of the head (6) in a freely rotatable manner housing the aforementioned transversal carrier (8). The framework (2) at each of its sides comprises a respective guide (11 and 12) along which the transversal carrier (8) is shiftable, and supports (18 and 19) for the fitting of the infant seat, said framework being mounted on a platform (17).
Patent RO-127229-A0 (RO)
Title: Solar still with heat recovery device
Inventor: RĂDULESCU REMI
IPC: F28B9/08
Filed: 2011-11-14
Abstract: The invention relates to a solar still with heat recovery device which carries out the water vaporization by using solar energy and the recovery of the heat resulting by water vapour condensation. According to the invention, the still comprises a pump () for supplying with pre-heated water which is controlled by a temperature sensor, a distribution pipe (), several connection pipes (), several nozzles () for spraying the water, a tube () wherein there takes place the water vaporization, a semicircular mirror () which focuses the solar radiations on the tube (), some metal fins () for increasing the catching surface, some transparent surfaces () which allow the solar radiations to pass towards the absorbent tube () and towards the fins () and to prevent the solar radiations from passing in opposite direction, a spherical vault () for storing the vapour, a pipe for the vapour (), a water-comprising vessel () for condensing the vapour and a condensing coil (), a pipe () for discharging the distilled water, a pipe () for supplying with cold water, a non-return flap () allowing the water to pass in a single direction, a pipe () for supplying the tube () with pre-heated water, an electric valve () with the role of adjusting a maximum level () and a minimum level (), respectively, for the water in the vaporizing tube (), a level bottle (), a pipe () for domestic hot water to the user, some closing valves () and a support () for fixing the constructive elements.
Patent RO-132771-A0 (RO)
Title: Process for making a selective pattern for the label free electrochemical detection of adiponectin in human biological samples
Inventor: MIHAILESCU CARMEN MARINELA
IPC: C23C18/42
Filed: 2017-11-27
Abstract: The invention relates to a process for preparing selective patterns for the electrochemical detection of adiponectin in human biological samples. According to the invention, the process consists in electrochemically cleaning the surface of a polycrystalline gold electrode by the immersion in water, isopropanol, ethanol, for 10 min each, and drying, verifying the cleaning degree by the electrochemical impedance spectrometry method, recording the cyclic voltammogram spectra by scanning, in the potential range 0...0.9 V, in phosphate buffer solution, with a scanning rate of 50 mV and 10 mV, electropolymerizing the electrode with 2 mM phenol in phosphate buffer solution, 10...15 cycles in the potential range 0...0.9 V, incubating the electrode at a temperature of 4°C with a volume of 40 μl adiponectin with a concentration of 50 μg/ml for 20 min, followed by incubating it for 16...18 h in deionized water, resulting in an adiponectin label free selective synthetic pattern.